Literature DB >> 9706126

Diabetic neuropathy.

A J Boulton1, R A Malik.   

Abstract

Better clinical characteristics and a standardized approach to the definition of neuropathy has enabled us to define more precisely the natural history of diabetic neuropathy. Detailed studies on the pathology and pathogenesis have allowed dissection of important pathogenetic pathways. Effective treatment is currently limited, although a number of new and potentially important therapeutic interventions, including modification of the vascular supply and antioxidant status and growth factors, may prove to be of benefit in preventing damage and also promoting repair of peripheral nerves in human diabetic neuropathy.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9706126     DOI: 10.1016/s0025-7125(05)70029-8

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN: 0025-7125            Impact factor:   5.456


  24 in total

Review 1.  Focal and multifocal neuropathies.

Authors:  Rayaz A Malik
Journal:  Curr Diab Rep       Date:  2002-12       Impact factor: 4.810

Review 2.  Targeting inflammation in diabetes: Newer therapeutic options.

Authors:  Neeraj Kumar Agrawal; Saket Kant
Journal:  World J Diabetes       Date:  2014-10-15

3.  The effect of exercise on the peripheral nerve in streptozotocin (STZ)-induced diabetic rats.

Authors:  Heung Yong Jin; Kyung Ae Lee; Tae Sun Park
Journal:  Endocrine       Date:  2014-09-25       Impact factor: 3.633

4.  Use of tricyclic antidepressants in older patients with painful neuropathies.

Authors:  Ariel Berger; Ellen M Dukes; John Edelsberg; Brett R Stacey; Gerry Oster
Journal:  Eur J Clin Pharmacol       Date:  2006-06-27       Impact factor: 2.953

5.  Structural abnormalities do not explain the early functional abnormalities in the peripheral nerves of the streptozotocin diabetic rat.

Authors:  D Walker; A Carrington; S A Cannan; D Sawicki; J Sredy; A J Boulton; R A Malik
Journal:  J Anat       Date:  1999-10       Impact factor: 2.610

6.  Temporal course of streptozotocin-induced diabetic polyneuropathy in rats.

Authors:  Yee-Fun Lee; Chou-Ching K Lin; Gin-Shin Chen
Journal:  Neurol Sci       Date:  2014-06-13       Impact factor: 3.307

7.  Corneal confocal microscopy: a non-invasive surrogate of nerve fibre damage and repair in diabetic patients.

Authors:  R A Malik; P Kallinikos; C A Abbott; C H M van Schie; P Morgan; N Efron; A J M Boulton
Journal:  Diabetologia       Date:  2003-05-09       Impact factor: 10.122

8.  Diabetes, lower extremity amputation, loss of protective sensation, and neuronal nitric oxide synthase associated protein in the chronic renal insufficiency cohort study.

Authors:  David J Margolis; Jayanta Gupta; Stephen R Thom; Raymond R Townsend; Peter A Kanetsky; Ole Hoffstad; Maryte Papdopoulos; Michael Fischer; Jeffrey R Schelling; Nandita Mitra
Journal:  Wound Repair Regen       Date:  2012-12-10       Impact factor: 3.617

9.  Evaluation of the efficacy of pulsed electromagnetic field in the management of patients with diabetic polyneuropathy.

Authors:  Vinay Graak; Sarika Chaudhary; B S Bal; J S Sandhu
Journal:  Int J Diabetes Dev Ctries       Date:  2009-04

10.  Prevalence and risk factors of gastroparesis-related symptoms among patients with type 2 diabetes.

Authors:  Rakan A Almogbel; Fulwa A Alhussan; Sulaiman A Alnasser; Metab A Algeffari
Journal:  Int J Health Sci (Qassim)       Date:  2016-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.